Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06315270

To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
The First Hospital of Jilin University · Academic / Other
Sex
Female
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This project proposes to elucidate the functional impact of T cells in cancer progression and treatment through a comprehensive TCR profiling study and a longitudinal cohort study in patients with advanced epithelial ovarian cancer. Our findings aim to provide clinical insights for monitoring treatment response in a non-invasive way and demonstrate the association of TCR diversity with clinical outcomes and the potential role of TCR profiling in cancer prognosis.

Conditions

Timeline

Start date
2024-03-20
Primary completion
2029-03-20
Completion
2029-03-20
First posted
2024-03-18
Last updated
2024-04-01

Source: ClinicalTrials.gov record NCT06315270. Inclusion in this directory is not an endorsement.